United Therapeutics Corp

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
United Therapeutics Corp
TickerUTHR
CIK #0001082554
CUSIP91307C102
SectorLife Sciences - Pharmaceutical Preparations
Address1040 Spring St, Silver Spring, MD 20910
Source [EDGAR]
CIK Filing 2011 - 2024
[0001082554] 10-K
[0001082554] 10-Q
[0001082554] 3
[0001082554] 4
[0001082554] 8-K
[0001082554] SC 13D
[0001082554] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Wellington Management Group LLP United Therapeutics Corp [2023-02-06] 5.64
United Therapeutics Corp Celularity Inc [2023-02-03] 6.51
United Therapeutics Corp Celularity Operations Inc [2022-02-04] 6.51
Avoro Capital Advisors LLC United Therapeutics Corp [2021-02-12] 6.4
United Therapeutics Corp Clene Inc [2021-01-08] 7.0
United Therapeutics Corp Transmedics Group Inc [2020-02-07] 6.89
Integrated Core Strategies US LLC United Therapeutics Corp [2019-08-12] 4.4
AQR Capital Management LLC United Therapeutics Corp [2019-02-14] 5.77
Renaissance Technologies LLC United Therapeutics Corp [2019-02-13] 5.04
United Therapeutics Corp SteadyMed Ltd [2018-05-07] 43.3
Scopia Capital Management LP United Therapeutics Corp [2015-02-17] 6.23
FMR LLC United Therapeutics Corp [2013-02-14] 0.0
LSV Asset Management United Therapeutics Corp [2013-02-13] 5.19
Vanguard Group Inc United Therapeutics Corp [2013-02-12] 5.06
Form 3/4/5 Filer 2011 - 2024
Thompson Tommy G
UNITED THERAPEUTICS Corp
Mahon Paul A
Giltner Richard
Patusky Christopher
Mesa Nilda
Rothblatt Martine A
Dwek Raymond
Sullivan Louis W
Benkowitz Michael
Causey Christopher
Olian Judy D.
Edgemond James
Kurzweil Ray
Maxwell Linda
Klein Katherine J
TransMedics Group, Inc.
Lung Biotechnology PBC
SteadyMed Ltd.
Zaccardelli David
Jeffs Roger
Ferrari John Maxim
Gray R Paul
Form 13F Holdings
Firm Period DFND Voting Shares
BlackRock Inc. [2023-03-31] SOLE 4,506,572.0 4,751,805.0
Vanguard Group Inc [2023-03-31] SOLE 0.0 4,547,053.0
Wellington Management Group LLP [2023-03-31] DFND 0.0 3,781,840.0
Avoro Capital Advisors LLC [2023-03-31] SOLE 2,870,000.0 2,870,000.0
FMR LLC [2023-03-31] DFND 2,516,403.0 2,537,457.0
Renaissance Technologies LLC [2023-03-31] SOLE 2,227,414.0 2,227,414.0
State Street Corp [2023-03-31] DFND 1,610,430.0 1,795,102.0
Janus Henderson Group PLC [2023-03-31] DFND 0.0 975,830.0
Geode Capital Management LLC [2023-03-31] DFND 751,384.0 759,143.0
Assenagon Asset Management S.A. [2023-03-31] SOLE 665,568.0 665,568.0
Farallon Capital Management LLC [2023-03-31] OTR 664,767.0 664,767.0
Palo Alto Investors LP [2023-03-31] SOLE 627,514.0 627,514.0
Bank of New York Mellon Corp [2023-03-31] DFND 491,171.0 604,535.0
Envestnet Asset Management Inc [2023-03-31] SOLE 536,184.0 536,184.0
Fuller & Thaler Asset Management Inc [2023-03-31] SOLE 523,557.0 523,594.0
Nuveen Asset Management LLC [2023-03-31] DFND 461,957.0 462,264.0
Dimensional Fund Advisors LP [2023-03-31] SOLE 399,364.0 420,102.0
LSV Asset Management [2023-03-31] SOLE 261,408.0 398,208.0
Northern Trust Corp [2023-03-31] DFND 46,901.0 395,146.0
AQR Capital Management LLC [2023-03-31] DFND 332,979.0 373,223.0
Invesco Ltd. [2023-03-31] DFND 0.0 349,917.0
Morgan Stanley [2023-03-31] DFND 255,102.0 342,892.0
First Trust Advisors LP [2023-03-31] SOLE 324,822.0 324,822.0
Polar Capital Holdings Plc [2023-03-31] DFND 324,075.0 324,075.0
Charles Schwab Investment Management Inc [2023-03-31] SOLE 314,029.0 314,029.0
Pictet Asset Management Sa [2023-03-31] DFND 1.0 288,418.0
AssetMark Inc [2023-03-31] DFND 270,423.0 270,423.0
Loomis Sayles & Co L P [2023-03-31] DFND 204,687.0 259,239.0
Millennium Management LLC [2023-03-31] SOLE 257,841.0 257,841.0
Jacobs Levy Equity Management Inc [2023-03-31] SOLE 212,467.0 257,290.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com